Simon Shorter

Title: Simon Shorter: Innovator in Oncofetal Fibronectin Detection

Introduction

Simon Shorter is a notable inventor based in Lake Forest, IL (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of oncofetal fibronectin. With a total of 4 patents, his work has the potential to impact health assessments and disease risk evaluations.

Latest Patents

Simon Shorter's latest patents focus on methods for detecting oncofetal fibronectin. These patents include innovative techniques and products for identifying oncofetal fibronectin indicating molecules in various samples. His methods involve treating samples with reagents and utilizing non-specific binders. Additionally, he has developed methods for imaging oncofetal fibronectin and testing subjects to ascertain health and disease status. His work also encompasses the use of immunoassays and mass spectrometry for detecting oncofetal fibronectin indicating molecules.

Career Highlights

Throughout his career, Simon Shorter has worked with prominent companies in the medical field, including Hologic, Inc. and Cytyc Corporation. His experience in these organizations has contributed to his expertise in developing diagnostic methods and products.

Collaborations

Simon has collaborated with notable professionals in his field, including Robert O Hussa and Mark Fischer-Colbrie. These collaborations have likely enhanced his research and development efforts in oncofetal fibronectin detection.

Conclusion

Simon Shorter is a distinguished inventor whose work in oncofetal fibronectin detection is paving the way for advancements in medical diagnostics. His innovative methods and collaborations reflect his commitment to improving health assessments and disease risk evaluations.